Skip to content
Nonprofiteer
← REGENERATIVE RESEARCH FOUNDATION

Form 990 for tax year 2024

Filed by REGENERATIVE RESEARCH FOUNDATION.

Totals

Total revenue
$7,006,538
Total expenses
$6,491,048
Contributions and grants received
$5,982,290
Grants paid
$0
Program service revenue
$782,345
Investment income
$75,008
Other revenue
$166,895
Total assets, end of year
$9,028,494
Total liabilities, end of year
$3,000,354
Net assets or fund balances, end of year
$6,028,140
Program services expenses (Part IX)
$5,188,569
Management and general expenses
$1,302,479
Fundraising expenses
$0
Program service expenses (Part III)
$5,188,569

Program services were 79.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $5,288,818

  • 1f · All other contributions, gifts and grants

    $693,472

  • 2a · Program service revenue: SPONSORED RESEARCH

    total $782,345 · related or exempt $782,345

  • 3 · Investment income

    total $75,008 · excluded $75,008

  • 5 · Royalties

    total $16,174 · excluded $16,174

  • 11a · Other revenue: NEURACELL INCOME

    total $145,769 · excluded $145,769

  • 11b · Other revenue: OTHER

    total $4,952 · excluded $4,952

  • 11e · Other revenue, total

    $150,721

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $249,374 · program services $239,582 · management and general $9,792

  • 7 · Other salaries and wages

    total $2,316,484 · program services $1,628,635 · management and general $687,849

  • 8 · Pension plan contributions

    total $72,236 · program services $55,601 · management and general $16,635

  • 9 · Other employee benefits

    total $171,699 · program services $132,447 · management and general $39,252

  • 10 · Payroll taxes

    total $193,661 · program services $152,229 · management and general $41,432

  • 11b · Fees: legal

    total $119,392 · program services $106,386 · management and general $13,006

  • 11c · Fees: accounting

    total $22,550 · management and general $22,550

  • 11g · Fees: other

    total $517,693 · program services $364,273 · management and general $153,420

  • 13 · Office expenses

    total $25,430 · program services $4,171 · management and general $21,259

  • 14 · Information technology

    total $34,053 · program services $12,316 · management and general $21,737

  • 16 · Occupancy

    total $391,625 · program services $372,827 · management and general $18,798

  • 17 · Travel

    total $46,089 · program services $21,163 · management and general $24,926

  • 19 · Conferences, conventions and meetings

    total $15,173 · program services $5,462 · management and general $9,711

  • 20 · Interest

    total $63 · management and general $63

  • 22 · Depreciation, depletion and amortization

    total $131,965 · program services $131,965

  • 23 · Insurance

    total $55,430 · management and general $55,430

  • 24a · Other expenses: RESEARCH SUBCONTRACTS

    total $1,225,862 · program services $1,225,862

  • 24b · Other expenses: LABORATORY CHARGES

    total $734,338 · program services $636,096 · management and general $98,242

  • 24c · Other expenses: EQUIP. REPAIR & MAINT.

    total $113,817 · program services $89,392 · management and general $24,425

  • 24d · Other expenses: MISCELLANEOUS

    total $54,114 · program services $10,162 · management and general $43,952

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $433,733 · end of year $37,872

  • 2 · Savings and temporary cash investments

    beginning of year $3,639,688 · end of year $4,962,960

  • 3 · Pledges and grants receivable

    beginning of year $1,809,146 · end of year $921,305

  • 4 · Accounts receivable

    beginning of year $206,672 · end of year $34,828

  • 9 · Prepaid expenses and deferred charges

    beginning of year $157,309 · end of year $110,640

  • 10a · Land, buildings and equipment: cost or other basis

    $4,547,955

  • 10b · Land, buildings and equipment: accumulated depreciation

    $3,813,856

  • 10c · Land, buildings and equipment, net

    beginning of year $486,977 · end of year $734,099

  • 15 · Other assets

    beginning of year $262,900 · end of year $2,226,790

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,221,043 · end of year $774,115

  • 25 · Other liabilities

    beginning of year $262,732 · end of year $2,226,239

  • 27 · Net assets without donor restrictions

    beginning of year $4,252,040 · end of year $4,780,002

  • 28 · Net assets with donor restrictions

    beginning of year $1,260,610 · end of year $1,248,138

Mission and programs · 2024

Mission

THE PRINCIPAL MISSION OF THE REGENERATIVE RESEARCH FOUNDATION IS TO DEVELOP REGENERATIVE STEM CELL THERAPIES FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS): THE BRAIN, SPINAL CORD, AND RETINA.

  • FISCAL YEAR 2024 WAS AN EVENTFUL AND PRODUCTIVE YEAR FOR THE REGENERATIVE RESEARCH FOUNDATION. ON OCTOBER 1, 2024 THE FOUNDATION MOVED TO A NEW LABORATORY FACILITY LOCATED IN ALBANY, NY. THE RELOCATION WAS ACCOMPLISHED WITHOUT INCIDENT AND RESEARCH ACTIVITIES RESUMED QUICKLY TO NORMAL LEVELS. FOUNDATION RESEARCHERS PUBLISHED SEVERAL ARTICLES IN PROMINENT SCIENTIFIC JOURNALS REPORTING THE RESULTS OF THEIR INVESTIGATIONS INTO NEURODEGENERATIVE DISEASES SUCH AS DEMENTIA AND POTENTIAL TREATMENTS FOR DISEASES OF THE NERVOUS SYSTEM. THESE PUBLICATIONS WERE MADE FREELY AVAILABLE TO THE RESEARCH COMMUNITY AND GENERAL PUBLIC THROUGH THE NATIONAL LIBRARY OF MEDICINE OPEN ACCESS REPOSITORY. THE FOUNDATION RESEARCHERS WERE ABLE TO SECURE 8 NEW GRANTS WHICH PROVIDE FINANCIAL SUPPORT FOR THEIR RESEARCH ACTIVITIES.

    Expenses $3,316,101 · Revenue $531,849

  • Withheld by Nonprofiteer: this text may name a private individual.

    Expenses $1,052,191 · Revenue $250,496

  • THE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS RESEARCH PROGRAM CONTINUED ITS MISSION TO EXPAND THE UNDERSTANDING AND DEVELOPMENT OF A POTENTIAL TREATMENT FOR THESE NEURODEGENERATIVE DISEASES. THE INSTITUTE SERVES AS THE LEAD ORGANIZATION FOR A CONSORTIUM OF INSTITUTIONS AND INVESTIGATORS FOCUSED ON IDENTIFYING GENES ASSOCIATED WITH THE DEVELOPMENT OF DEMENTIA. THE NATIONAL INSTITUTES OF HEALTH AND SEVERAL PUBLIC CHARITIES SUPPORT THIS UNDERTAKING BOTH PROGRAMMATICALLY AND FINANCIALLY. THE FOUNDATION IS SEEKING BIOTECH PARTNERSHIPS TO SUPPORT RESEARCH AND DEVELOPMENT OF A PROMISING NEURODEGENERATIVE DISEASE TREATMENT.

    Expenses $820,277

As filed on the 2024 return. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Listed in Part VII

  • William Kahn CPA

    CHAIR

    Total calculated
    $0
    Hours/week
    5

  • Jeffrey H Stern MD PhD

    DIRECTOR FOR TRANSLATIONAL

    Total calculated
    $53,535
    From this org
    $53,025
    From related orgs
    $0
    Other
    $510
    Hours/week
    30

  • John Walsh

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Vito Grasso Mpa Cae

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • David O Carpenter MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Dawn Abbuhl

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Robert Catalano MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Amy G Klann PhD JD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Sally Temple-Stern PhD

    SCIENTIFIC & EXECUTIVE DIR

    Total calculated
    $195,839
    From this org
    $173,942
    From related orgs
    $0
    Other
    $21,897
    Hours/week
    65

    Schedule J breakdown matched by us

    Base
    $173,942
    Bonus
    $0
    Other
    $0
    Deferred
    $7,200
    Nontaxable benefits
    $14,697
    Filer's total
    $195,839

  • Caitlin Hill

    PRINCIPAL INVESTIGATOR

    Total calculated
    $141,811
    From this org
    $135,055
    From related orgs
    $0
    Other
    $6,756
    Hours/week
    40

  • Thomas Kiehl

    PRINCIPAL INVESTIGATOR

    Total calculated
    $146,182
    From this org
    $131,200
    From related orgs
    $0
    Other
    $14,982
    Hours/week
    40

  • Glenna Ford

    CLINICAL TRIAL MANAGER

    Total calculated
    $155,013
    From this org
    $139,694
    From related orgs
    $0
    Other
    $15,319
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $139,694
    Bonus
    $0
    Other
    $0
    Deferred
    $5,600
    Nontaxable benefits
    $9,719
    Filer's total
    $155,013

  • David Butler PhD

    PRINCIPAL INVESTIGATOR

    Total calculated
    $106,855
    From this org
    $101,541
    From related orgs
    $0
    Other
    $5,314
    Hours/week
    60

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
5 August 2025
IRS schema version
2024v5.2
Source object
202532179349300708

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.